Harmony Biosciences director granted 21,872 stock options
Harmony Biosciences Holdings director Graf R. Mark received a new stock option grant covering 21,872 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Harmony Biosciences Holdings director Graf R. Mark received a new stock option grant covering 21,872 shares of common stock. The options have an exercise price of $30.76 per share and expire on May 14, 2036. They vest in full on the earlier of May 14, 2027 or the next annual meeting, subject to his continued service. After this grant, he holds 21,872 stock options directly according to this filing.
Insider Trade Summary
Grant/Award: 21,872 shares
Grant/Award
1 txn
Insider
Graf R. Mark
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 21,872 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 21,872 contracts (Direct)
Footnotes (1)
- F1. The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
Key Figures
Option grant size: 21,872 options
Exercise price: $30.76 per share
Expiration date: May 14, 2036
+3 more
6 metrics
Option grant size
21,872 options
Stock option award to director Graf R. Mark
Exercise price
$30.76 per share
Conversion/exercise price of granted options
Expiration date
May 14, 2036
Option term end for this grant
Vesting date trigger
May 14, 2027 or next annual meeting
Full vesting, subject to continued service
Post-grant derivative holdings
21,872 options
Total options held directly after transaction
Transaction price paid
$0.00 per option
Grant/award acquisition, no purchase price
Key Terms
Stock Option, grant/award acquisition, underlying security, vesting, +1 more
5 terms
Stock Option financial
"security_title: "Stock Option""
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
grant/award acquisition financial
"transaction_action: "grant/award acquisition""
underlying security financial
"underlying_security_title: "Common Stock""
vesting financial
"The stock option shall vest in full on the earlier to occur of (i) May 14, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion_or_exercise_price: "30.7600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Harmony Biosciences (HRMY) report for Graf R. Mark?
Harmony Biosciences reported that director Graf R. Mark received a stock option grant for 21,872 shares of common stock. This is a compensation-related award rather than an open-market trade, reflecting additional equity-based incentive tied to the company’s share price performance.
What is the exercise price of Graf R. Mark’s new HRMY stock options?
The granted stock options have an exercise price of $30.76 per share. This means he can buy Harmony Biosciences common stock at $30.76 once the options vest, if exercising before the May 14, 2036 expiration date.
When do Graf R. Mark’s Harmony Biosciences stock options vest?
The stock options vest in full on the earlier of May 14, 2027 or the date of the next annual meeting following the grant. Vesting is contingent on his continued service through the applicable vesting date, aligning incentives with ongoing board service.
When do Graf R. Mark’s newly granted HRMY stock options expire?
The stock options expire on May 14, 2036. After that date, any unexercised options will no longer be usable, so potential benefits from the grant depend on Harmony Biosciences’ share price and his exercise decisions before expiration.
How many Harmony Biosciences options does Graf R. Mark hold after this grant?
Following this transaction, Graf R. Mark holds 21,872 stock options directly according to the filing. This amount matches the newly granted options, indicating his derivative position in Harmony Biosciences common stock is fully represented by this single award.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates